As Canada continues to make strides in the field of biotechnology, a new frontier is emerging at the intersection of mental health and psychedelic research. The potential for psychedelic drugs to revolutionize treatments for various mental health conditions has attracted significant interest, and Canadian biotechnology companies are at the forefront of this groundbreaking research. In this blog, we’ll delve into how these companies are shaping the future of mental health care, the legal landscape in Canada, and what makes this area of biotech so exciting.
